Baroreflex dysfunction in chronic kidney disease

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Physiology

Background:

• Patients with chronic kidney disease (CKD) exhibit elevated cardiovascular mortality and morbidity.
• Traditional and CKD-specific risk factors contribute to accelerated vascular calcification in these individuals.
• Vascular calcification is linked to reduced arterial compliance, impaired baroreflex sensitivity (BRS), and consequently, increased blood pressure (BP) variability, hindering BP regulation.

Purpose of the Study:

• To review the physiology of the baroreflex and methods for assessing its function.
• To examine the determinants and prognostic significance of BRS assessment in CKD patients.
• To synthesize current literature on BRS in CKD and elucidate the underlying pathophysiology of baroreflex dysfunction.

Main Methods:

• Literature review of baroreflex physiology and function assessment.
• Analysis of studies investigating BRS in chronic kidney disease populations.
• Discussion of pathological mechanisms contributing to baroreflex impairment in CKD.

Main Results:

• Baroreflex dysfunction, characterized by impaired BRS, is prevalent in CKD patients.
• Vascular calcification and associated arterial stiffening are key contributors to baroreflex impairment.
• Reduced BRS in CKD is associated with poorer BP control and increased cardiovascular risk.

Conclusions:

• Baroreflex sensitivity is significantly impaired in patients with chronic kidney disease.
• Understanding baroreflex dysfunction is crucial for managing cardiovascular complications in CKD.
• Further research into therapeutic strategies targeting baroreflex function may improve outcomes for CKD patients.